Nanoparticle to Nanoparticle Bioorthogonal Detection of Atherosclerosis.

ACS Appl Mater Interfaces · 2025 · PMC12532092 · PMID 41048110

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Furthermore, while the differences between the full pretargeted approach group and the two control groups were highly significant, the differences between the control groups were not significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.